BBPWM
GSK icon

Blue Bell Private Wealth Management’s GSK GSK Stock Holding History

Blue Bell Private Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4
Closed -$2K – 325
2016
Q3 		$2K Buy
+4
New +$219 ﹤0.01% 410

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Blue Bell Private Wealth Management's GSK Position: Q3 2022 in Review

Blue Bell Private Wealth Management sold out of GSK (GSK) in Q3 2022, closing a stake of 2,418 shares — an estimated $132K sold.

Blue Bell Private Wealth Management first reported a position in GSK in Q4 2013 and held it in 15 quarters. The position peaked at $580K in Q3 2014. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Blue Bell Private Wealth Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 2,418 GSK shares in Q3 2022, an estimated $132K.
  • Blue Bell Private Wealth Management first reported a position in GSK in Q4 2013 and held it in 15 quarters.
  • Blue Bell Private Wealth Management's GSK position peaked at $580K in Q3 2014.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q3 2022, filed 9 Nov 2022.